FDA-Drug2024-05-01Class III
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd.
Hazard
Cross Contamination with Other Products
Sold states
USA nationwide.
Affected count
N/A
Manufactured in
224-18, Kawauchi-Cho, Tokushima, N/A, Japan
Products
Abilify (aripiprazole), 10 mg tablets, packaged in a) 30 count bottles (NDC 59148-008-13) and b) 7 count blister packs (NDC 59148-008-95), RX only, Otsuka America Pharmaceutical, Inc.
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0467-2024Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief